-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓USDISIN US87166B1026
ISIN US87166B1026
WKN A2JBKW
Symbol SYNH
Währung
USD
Firmenname
Syneos Health, Inc
Marktkapitalisierung
7.479.323.328 (+- 7%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
8.024.646.656 oder 6.934.000.000
Mitarbeiter
26.539 (+- 8%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
24.310 oder 28.768 Mitarbeiter
KGV
42.29
EBITDA 575.150.976
PEGRatio 2.0229
Buchwert 31.194
Syneos Health Inc A outperformed den DAX um +258 % vom 07.11.2014 bis 18.06.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 79,54 USD +0,90%
Entdecke die 6 ETFs in denen Syneos Health, Inc am höchsten gewichtet ist Insgesamt in 9 ETFs enthalten
Dir gefallen die Informationen zu Syneos Health Inc A?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Syneos Health Inc A?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Syneos Health Inc A?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Syneos Health Inc A?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
27 News & Informationen zur Syneos Health Inc A Aktie
Syneos Health (SYNH) Hits a 52-Week High: What's Driving It?
Strong performance by the Clinical Solutions and Commercial Solutions segments drove Syneos Health's (SYNH) top line.
15 Best Mid-Cap Stocks for 2021
Mid-cap stocks are considered in the middle of small-cap and large-cap stocks. While mid-cap (i.e.
Dow Jones Jumps As Powell Backs This; Tesla Gains As Elon Musk Steps Up; 5 Stocks Pass Buy
The Dow Jones Industrial Average charged higher after a speech by Federal Reserve Chairman Jerome Powell. Tesla (TSLA) moved higher after the firm finally
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 183 stocks hit new 52-week highs.
Areas of Significance: Alphabet (NASDAQ:GOOG) was the biggest firm by market cap …
VRPX Stock Halted Repeatedly As Shares Rocket Out of Penny Stock Territory
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) more than tripled today on FDA-related news about its anti-viral barrier product.
Syneos Health (SYNH) Q2 Earnings Top Estimates, 2021 View Up
Syneos Health (SYNH) reported better-than-expected revenues for the second quarter of 2021 on strong segmental performance.
Syneos Health, Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:SYNH)
The following slide deck was published by Syneos Health, Inc.
Syneos Health, Inc. (SYNH) CEO Alistair Macdonald on Q2 2021 Results – Earnings Call Transcript
Syneos Health, Inc. (NASDAQ:SYNH) Q2 2021 Earnings Conference Call August 9, 2021 08:00 ET Company Participants Ronnie Speight – Senior Vice President, Investor Relations Alistair Macdonald…
Syneos Health Reports Second Quarter 2021 Results
Highlights Second quarter revenue of $1,282.6 million, increased 6.1% sequentially and 26.6% year-over-year.Clinical Solutions net new business awards…
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of …
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnin…
Real World Evidence Solutions Market worth $2.3 billion by 2026 – Exclusive Report by MarketsandMarkets™
/PRNewswire/ — According to the new market research report “Real World Evidence/RWE Solutions Market by Component (Dataset (Claims, Clinical, Pharmacy,…
Syneos Health Inc (SYNH) CEO Alistair Macdonald Sold $3.6 million of Shares
GuruFocus Article or News written by insider and the topic is about:
The Worldwide Contract Research Organization Services Industry Is Expected To Reach $86.5 Billion By 2026
DUBLIN, Aug. 3, 2021 /PRNewswire/ — The “Global Contract Research Organization (CROs) Services Market by Type (Early phase, Clinical, Laboratory), Therapeutic
Is CAE, Inc. (CAE) A Good Stock To Buy?
In this article we are going to use hedge fund sentiment as a tool and determine whether CAE, Inc. (NYSE:CAE) is a good investment right now. We like…
Physicians Financial Services, Inc. Buys Qualcomm Inc, Archer-Daniels Midland Co, Pfizer Inc, Sells Syneos Health Inc, Delta Air Lines Inc, Best Buy Co Inc
GuruFocus Article or News written by insider and the topic is about:
Hedge Funds Are Dumping Genpact Limited (G)
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually…
Hedge Funds Are Dumping Knight-Swift Transportation Holdings Inc. (KNX)
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting…
Shoreline Biosciences Strengthens Senior Management Team With Three Key Hires
SAN DIEGO, July 13, 2021 /PRNewswire/ — Shoreline Biosciences, Inc. , a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized, and targeted induced…
Syneos Health Schedules Second Quarter 2021 Earnings Call for Monday, August 9, 2021
MORRISVILLE, N.C., July 12, 2021 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization,…
Hedge Funds Are Selling Syneos Health, Inc. (SYNH)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
Hedge Funds Aren’t Crazy About DXC Technology Company (DXC) Anymore
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession…
The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ju…
Is RenaissanceRe Holdings Ltd. (RNR) Going to Burn These Hedge Funds?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900…
Is Pearson PLC (PSO) A Good Stock To Buy?
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms…
Syneos Health Accelerates Decentralized Clinical Trial Delivery, Unveils New Collaboration with Site Sponsors
MORRISVILLE, N.C., June 21, 2021 — Syneos Health® , the only fully integrated biopharmaceutical solutions organization, today expanded its Decentralized Clinical Trial capabilities to… | June 21, 2021
Syneos Health Accelerates Decentralized Clinical Trial Delivery, Unveils New Collaboration with Site Sponsors
Newly Established Site Advocacy Group will Deliver Deeper, More Meaningful Site-Based Insights to Drive Adoption of Decentralized Clinical Trials…